The role of L-3-1-123-iodine-α-methyl tyrosine-SPECT in cerebral gliomas
暂无分享,去创建一个
[1] K. Langen,et al. Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] M Schwaiger,et al. First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas. , 2000, International journal of radiation oncology, biology, physics.
[3] O. Schober,et al. Sequential scintigraphic strategy for the differentiation of brain tumours , 2000, European Journal of Nuclear Medicine.
[4] M. Weckesser,et al. Evaluation of the Extension of Cerebral Gliomas by Scintigraphy , 2000, Strahlentherapie und Onkologie.
[5] J. Moringlane,et al. Evaluation of l-3-[123I]iodo-α-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy , 1999, European Journal of Nuclear Medicine.
[6] H. Groen,et al. Feasibility of tumor imaging using L-3-[iodine-123]-iodo-alpha-methyl-tyrosine in extracranial tumors. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] K. Zilles,et al. Comparison of iodotyrosines and methionine uptake in a rat glioma model. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] T. Morioka,et al. Delayed cerebral radionecrosis with a high uptake of 11C-methionine on positron emission tomography and 201Tl-chloride on single-photon emission computed tomography , 1998, Neuroradiology.
[9] O. Schober,et al. Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] S. Goldman,et al. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] D. Kinzel,et al. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] S. Goldman,et al. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma. , 1996, Neurosurgery.
[13] E. Ryding,et al. Preoperative grading of glioma malignancy with thallium-201 single-photon emission CT: comparison with conventional CT. , 1996, AJNR. American journal of neuroradiology.
[14] I. Kanno,et al. Carbon-11-methionine PET evaluation of intracerebral hematoma: distinguishing neoplastic from non-neoplastic hematoma. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] A. Jacobs,et al. Amino acid uptake in ischemically compromised brain tissue. , 1995, Stroke.
[16] K. Sartor,et al. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. , 1995, Neurosurgery.
[17] R. Iwata,et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] A. Luxen,et al. Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] E. Jackson,et al. Current imaging techniques for the evaluation of brain neoplasms. , 1994, Current opinion in oncology.
[20] K Herholz,et al. Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study. , 1993, Journal of neurosurgery.
[21] M. Senda,et al. Re-evaluation of amino acid PET studies: can the protein synthesis rates in brain and tumor tissues be measured in vivo? , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] Iwao Kanno,et al. High L‐Methyl‐[11C]Methionine Uptake in Brain Abscess: A PET Study , 1993, Journal of computer assisted tomography.
[23] K Wienhard,et al. Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] Y. Yonekura,et al. A strategy for the study of cerebral amino acid transport using iodine-123-labeled amino acid radiopharmaceutical: 3-iodo-alpha-methyl-L-tyrosine. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] M. Bergström,et al. Delineation of Gliomas with Magnetic Resonance Imaging Using Gd-DTPA in Comparison with Computed Tomography and Positron Emission Tomography , 1990, Acta radiologica.
[26] H. Herzog,et al. SPECT studies of brain tumors with L-3-[123I] iodo-alpha-methyl tyrosine: comparison with PET, 124IMT and first clinical results. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] A. Syrota,et al. [11C]L-methionine uptake in gliomas. , 1989, Neurosurgery.
[28] M. Bergström,et al. Positron Emission Tomography Compared with Magnetic Resonance Imaging and Computed Tomography in Supratentorial Gliomas Using Multiple Stereotactic Biopsies as Reference , 1989, Acta radiologica.
[29] M. Bergström,et al. Positron Emission Tomography with 11C-Methionine and Computed Tomography of Intracranial Tumours Compared with Histopathologic Examination of Multiple Biopsies , 1987, Acta radiologica.
[30] O. Schober,et al. Kinetics of 3-[(123)I]iodo-l-alpha-methyltyrosine transport in rat C6 glioma cells. , 1999, European journal of nuclear medicine.
[31] O. Schober,et al. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[32] Susan M. Chang,et al. 18‐fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma , 1997, Cancer.
[33] H. Herzog,et al. Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine. , 1997, European journal of nuclear medicine.
[34] O. Schober,et al. Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions. , 1996, European journal of nuclear medicine.
[35] N. Rollins,et al. Comparison of gadolinium-enhanced MR and thallium-201 single photon emission computed tomography in pediatric brain tumors. , 1995, Pediatric neurosurgery.
[36] K. Dutschka,et al. Anreicherung von DL-3-123I-Jod-α-Methyltyrosin in Hirntumorrezidiven , 1995, Nuklearmedizin.
[37] A. Bockisch,et al. Imaging of Brain Tumors with L-3-[123I]Iodo-α-Methyl Tyrosine and SPECT , 1989 .
[38] Brain and Brain Tumor Uptake of L-3-['231]Iodo a.-MethylTyrosine: Competition with Natural L-Amino Acids , 2022 .